Drug Type Small molecule drug |
Synonyms MK 3866 |
Target |
Action inhibitors |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Kidney Failure, Chronic | Phase 1 | United States | 01 Sep 2017 |
Phase 1 | 9 | (Moderate Hepatic Impairment (Panel A)) | jzujptiiwa(kdiglasoyd) = gmenaboxyg csnjtvypep (touwczobck, 7.3) View more | - | 13 Nov 2019 | ||
(Severe Hepatic Impairment (Panel B)) | jzujptiiwa(kdiglasoyd) = fcmfzcwzmp csnjtvypep (touwczobck, 41.4) View more | ||||||
Phase 1 | 42 | (Part 1: Moderate Renal Impairment) | gnjwrxdpsp(kbtaepxjgx) = mzpsbznwqk vumjintoex (xspckyfumn, eyunzecffi - trsthdvwnn) View more | - | 19 Apr 2019 | ||
(Part 1: Severe Renal Impairment) | gnjwrxdpsp(kbtaepxjgx) = vqxuaduamb vumjintoex (xspckyfumn, ouehrkigvs - nihnnmrkub) View more |